NCT07197307
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07197307
Title Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) (CLEAR)
Acronym CLEAR
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Universitat Munster
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.